Biased AI warnings and experimental CRISPR therapies News-thread


Meredith Broussard is unusually well positioned to dissect the ongoing hype around AI. She is a data scientist and associate professor at New York University, and has been one of the leading researchers in the field of algorithmic bias for years.

And while her own work leaves her buried in math problems, she’s spent the last few years thinking about problems that math can’t solve. Broussard argues that we are constantly too eager to apply artificial intelligence to social problems in inappropriate and damaging ways, particularly when race, gender, and ability are not taken into account.

Broussard spoke with our Tate senior tech policy reporter Ryan-Mosley about the problems with police use of technology, the limits of “AI equity” and the solutions he sees to some of the challenges it poses. the AI. Read the full story.

More than 200 people have been treated with experimental CRISPR therapies

Jessica Hamzelou, a senior biotech reporter at MIT Technology Review, has spent the past few days listening to scientists, ethicists, and patient groups wrestling with emotional and ethical dilemmas.

They have been debating how, when and if we should use gene editing tools to change the human genome at the Third International Summit on Human Genome Editing in London.

There’s a lot to get excited about. In the decade since scientists discovered they could use CRISPR to edit cellular genomes, the technology has already been used to save some lives and transform others.


Please enter your comment!
Please enter your name here